Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.32 USD | +1.37% | +7.14% | -19.03% |
Business Summary
Number of employees: 712
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-opioid Pain Management and Regenerative Health Solutions
100.0
%
| 667 | 100.0 % | 675 | 100.0 % | +1.22% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 667 | 100.0 % | 675 | 100.0 % | +1.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Lee
CEO | Chief Executive Officer | 56 | 02/01 |
Director of Finance/CFO | 63 | 01/11/01 | |
Jonathan Slonin
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/21/01 |
Anthony Molloy
CMP | Compliance Officer | 50 | - |
Kristen Williams
ADM | Chief Administrative Officer | 50 | 01/11/01 |
Daryl Gaugler
COO | Chief Operating Officer | 62 | 01/19/01 |
Susan Mesco
IRC | Investor Relations Contact | - | 01/15/01 |
Max Reinhardt
PRN | Corporate Officer/Principal | 53 | 19/19/19 |
Corporate Officer/Principal | 52 | 19/23/19 | |
Lauren Riker
PRN | Corporate Officer/Principal | 45 | 21/12/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Pace
BRD | Director/Board Member | 76 | 01/08/01 |
Paul Hastings
CHM | Chairman | 64 | 02/11/02 |
Andreas Wicki
BRD | Director/Board Member | 64 | 01/06/01 |
Laura Brege
BRD | Director/Board Member | 66 | 02/11/02 |
Director/Board Member | 69 | 12/13/12 | |
Alethia Young
BRD | Director/Board Member | 45 | 10/23/10 |
Marcelo Bigal
BRD | Director/Board Member | - | 10/23/10 |
Mark Froimson
BRD | Director/Board Member | 63 | 15/17/15 |
Frank Lee
CEO | Chief Executive Officer | 56 | 02/01 |
Director/Board Member | 61 | 18/19/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 46,523,185 | 45,935,636 ( 98.74 %) | 0 | 98.74 % |
Company contact information
Pacira Biosciences, Inc.
5401 West Kennedy Boulevard Suite 890
33609, Tampa
+813 553 6680
http://www.pacira.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.03% | 1.27B | |
+29.68% | 681B | |
+20.63% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.55% | 235B | |
+4.30% | 199B | |
-11.00% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- PCRX Stock
- Company Pacira BioSciences, Inc.